دورية أكاديمية
Vaginal atrophy and genital pain in women on depot medroxyprogesterone acetate contraceptive injection.
| العنوان: | Vaginal atrophy and genital pain in women on depot medroxyprogesterone acetate contraceptive injection. |
|---|---|
| المؤلفون: | Perkins N; Auckland Sexual Health Service, Te Whatu Ora/Te Toka Tumai, Auckland, New Zealand. |
| المصدر: | The Australian & New Zealand journal of obstetrics & gynaecology [Aust N Z J Obstet Gynaecol] 2024 Apr; Vol. 64 (2), pp. 160-164. Date of Electronic Publication: 2023 Oct 10. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0001027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-828X (Electronic) Linking ISSN: 00048666 NLM ISO Abbreviation: Aust N Z J Obstet Gynaecol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Melbourne : Wiley-Blackwell Original Publication: Melbourne : Royal Australian and New Zealand College of Obstetricians and Gynaecologists |
| مواضيع طبية MeSH: | Dyspareunia*/drug therapy , Vaginal Diseases* , Contraceptive Agents, Female*/adverse effects, Humans ; Female ; Medroxyprogesterone Acetate/adverse effects ; Contraceptive Agents ; Pain ; Atrophy/chemically induced ; Atrophy/drug therapy ; Genitalia ; Medroxyprogesterone |
| مستخلص: | Depot medroxyprogesterone acetate causes a hypo-estrogenic state in over half of users although clinical vaginal atrophy causing superficial dyspareunia is thought rarely to occur. This is a case series of ten women using depot medroxyprogesterone acetate who presented with superficial dyspareunia and clinical vaginal atrophy. The women were treated with vaginal estriol cream and their contraception was discontinued or changed. All patients had either a complete resolution of symptoms or a substantial improvement at follow-up, and the clinical and laboratory findings of vaginal atrophy had resolved. This case series demonstrates that vaginal atrophy may occur more frequently than previously thought. (© 2023 Royal Australian and New Zealand College of Obstetricians and Gynaecologists.) |
| References: | Schivone G, Dorflinger L, Halpern V. Injectable contraception: Updates and innovation. Curr Opin Obstet Gynecol 2016; 28(6): 504–509. Burke AE. The state of hormonal contraception today: Benefits and risks of hormonal contraceptives: Progestin‐only contraceptives. Am J Obstet Gynecol 2011; 205(4 SUPPL): S17. Black A, Guilbert E, Costescu D et al. Canadian contraception consensus (part 3 of 4): Chapter 8—progestin‐only contraception. J Obstet Gynaecol Can 2016; 38(3): 279–300. Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: A review. J Sex Med 2012; 9(9): 2213–2223. Walker C, Badawy SZA. Vaginal atrophy following long‐term depot medroxyprogesterone acetate use: A case report. Case Rep Obstet Gynecol 2013; 2013: 1–3. Hodgins MB, Spike RC, Mackie RM, MacLean AB. An Immunohistochemical study of androgen, Oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol 1998; 105: 216–222. Goldstein I, Dicks B, Kim NN, Hartzell R. Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women. Sex Med 2013; 1(2): 44–53. Phillips NA, Bachmann GA. The genitourinary syndrome of menopause. Menopause 2021; 28(5): 579–588. McEndree B. Clinical application of the vaginal maturation index. Nurse Pract 1999; 24(9): 48–56. Haider S, Darney PD. Injectable contraception. Clin Obstet Gynecol 2007; 4: 898–906. Miller L, Patton DL, Meier A et al. Depomedroxyprogesterone‐induced Hypoestrogenism and changes in vaginal Flora and Epithelium. Obstet Gynecol 2000; 96: 431–439. Ralph LJ, Gollub EL, Jones HE. Hormonal contraceptive use and women's risk of HIV acquisition: Priorities emerging from recent data. Curr Opin Obstet Gynecol 2015; 27(6): 487–495. |
| فهرسة مساهمة: | Keywords: atrophy; dyspareunia; medroxyprogesterone acetate; sexual dysfunction; vaginal diseases |
| المشرفين على المادة: | C2QI4IOI2G (Medroxyprogesterone Acetate) 0 (Contraceptive Agents) 0 (Contraceptive Agents, Female) HSU1C9YRES (Medroxyprogesterone) |
| تواريخ الأحداث: | Date Created: 20231011 Date Completed: 20240418 Latest Revision: 20240920 |
| رمز التحديث: | 20240921 |
| DOI: | 10.1111/ajo.13757 |
| PMID: | 37817446 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1479-828X |
|---|---|
| DOI: | 10.1111/ajo.13757 |